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Background: Biological factors have been associated with deliberate self-harm (DSH) but have not been integrated
with clinical factors in routine risk assessments.
This study aimed to examine the incremental validity of lipid levels and platelet serotonin when combined with
psychosocial factors in risk assessments for repeated admissions due to DSH.
Methods: In this prospective observational study of 196 acutely admitted patients, results of blood tests performed
upon admission and the MINI Suicidal Scale and psychosocial DSH risk factor assessments performed at discharge
were compared with the incidence of DSH recorded during the first 3 and 12 months after discharge.
Results: High triglyceride levels were found to be a significant marker for patients admitted 3 or more times due to
DSH (repeated DSH, DSH-R) when tested against other significant risk factors. When all (9) significant univariate
factors associated with 12-month post-discharge DSH-R were analyzed in a multivariate logistic regression, the
MINI Suicidal Scale (p = 0.043), a lack of insight (p = 0.040), and triglyceride level (p = 0.020) remained significant. The
estimated 12-month area under the curve of the receiver operator characteristic (ROC-AUC) for DSH-R was 0.74 for
triglycerides, 0.81 for the MINI, 0.89 for the MINI + psychosocial factors, and 0.91 for the MINI + psychosocial
factors + triglycerides. The applied multifaceted approach also significantly discriminated between 12-month
post-discharge DSH-R patients and other DSH patients, and a lack of insight (p = 0.047) and triglycerides (p = 0.046)
remained significant for DSH-R patients in a multivariate analysis in which other DSH patients served as the
reference group (rather than non-DSH patients).
Conclusion: The triglyceride values provided incremental validity to the MINI Suicidal Scale and psychosocial risk
factors in the assessment of the risk of repeated DSH. Therefore, a bio-psychosocial approach appears promising,
but further research is necessary to refine and validate this method.
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Many risk factors contribute to suicide and self-harming
behavior [1]. Performing a full risk assessment of such
behavior is therefore time-consuming and requires ex-
pertise [2]. However, acute settings are characterized by
time pressure and high patient turnover. Screening in-
struments, such as the MINI Suicidal Scale, have been
shown to help identify patients at risk for self-harm [3],
and a 27-item scale based on 154 items from a collection
of suicidal assessment instruments showed promise for
the development of a new scale evaluating suicidal risk
in settings in which time is limited [4].
Patients who are repeatedly hospitalized because of
deliberate self-harm represent a special challenge for
emergency units [5]. In a study of patients admitted to
emergency wards after a suicide attempt, the Suicide
Assessment Scale (SUAS, a 20-item scale) was found to
perform well in screening for repeated suicide attempts in
patients receiving ongoing psychiatric treatment but less
well in screening for repeated suicide attempts in the
entire study population [6]. A recent multicenter study
showed that clinical decision rules based on 5 variables
(gender, current psychiatric treatment, previous self-harm,
antidepressant treatment, and/or self-poisoning with ben-
zodiazepines) could be used to enhance risk assessment of
repeated deliberate self-harm (DSH-R) in patients admit-
ted to emergency units [7].
Biological factors have been associated with suicidal
behavior [8,9], and it has been suggested that a model that
integrates feasible biological markers and clinical risk
factors could optimize the assessment of suicide risk [10].
Meta-analyses have shown that the 5-hydroxyindolacetate
levels in cerebrospinal fluid and a positive dexamethasone
test (DST) associated with mood disorders are significant
markers of prospective suicide risk and that combining
these two methods increases predictive accuracy [10]. One
study demonstrated that serum cholesterol concentrations
may be combined with DST results to provide a clinically
useful estimate of suicide risk in depressed patients [11].
However, with the exception of total cholesterol, these
tests are difficult to integrate into routine clinical practice
in acute settings. Many cross-sectional and retrospective
studies have revealed a significant correlation between
lipids and self-harm [12-16]. However, two prospective
studies found no associations between serum cholesterol
levels in depressed patients and subsequent suicide at-
tempts [17,18].
In a prospective study examining different screening
methods for deliberate self-harm risk during the first year
after discharge from an emergency psychiatric ward, we
found that (i) high triglyceride (TG) levels [19], (ii) the
MINI Suicidal Scale [3], and (iii) patients’ own estimates
of future risk (Self-report Risk Scale) [20] were significant
predictors of self-harming behavior following dischargefrom an emergency psychiatric ward. The present research
aimed to test the incremental validity of a biological
marker (TG levels) when combined with other risk factors
to identify patients at risk for repeatedly being hospitalized
due to self-harming behavior.
Methods
An observational follow-up study was performed at the
acute psychiatric ward of Aalesund Hospital in Norway,
which serves a population of 125,000 individuals. The
target group consisted of all patients who were acutely
admitted from March 7, 2006, to March 7, 2007. Of these
489 patients, 254 (52%) provided written consent and
were included in the study. Fifty-eight patients were lost
to follow-up after discharge. Thus, the final study group
consisted of 196 patients (40%) who were followed-up
1 year after discharge. The project was approved by the
Regional Committee for Medical Research Ethics and the
Ministry of Health and Care. Further information con-
cerning the study methodology is included in previous
reports [3,19].
Consenting patients provided a fasting blood sample 1
to 3 days after admission. At discharge, the patients’
therapists in the acute ward scored them based on
the MINI Suicidal Scale and the Self-report Risk Scale.
Other baseline variables were obtained from medical
records.
Follow-up at 3 and 12 months after discharge was
conducted by the patients’ therapists at outpatient psy-
chiatric clinics or district psychiatric wards. Patients dis-
charged to the community were monitored by their
psychiatric nurse in the acute ward. Self-harm episodes
were recorded during the 0–3-, 4–6-, 7–9-, and 10–12-
month periods. Information was collected from patients
and collaterals and from inpatient and outpatient hos-
pital records.
Baseline variables
Lipids and serotonin: Total cholesterol, low-density lipo-
protein (LDL), high-density lipoprotein (HDL), and TG
levels were measured in fasting blood serum, and sero-
tonin was measured in blood platelets [19]. The fasting
period was from 12:00 PM until blood was drawn at
8:00-9:00 AM the next morning.
The MINI Suicidal Scale is a subscale of the MINI
neuropsychiatric interview [21]. We used a short, 6-item
version of this instrument. Each item is scored yes = 1 or
no = 0. Items 1-5 evaluate whether an event has oc-
curred during the last month. The 6 included items are
as follows: (1) do you think that you would be better off
dead or wish you were dead; (2) do you want to harm
yourself or to hurt or injure yourself; (3) do you think
about suicide; (4) do you have a suicide plan; (5) have
you attempted suicide; and (6) in your lifetime, did you
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sponses to the MINI items (0-6) was recorded for fur-
ther analyses.
Self-report Risk Scale (SRS): Because of the lack of
available instruments, the SRS was constructed for this
study to measure patients’ judgment regarding their own
subsequent risk of self-harming behavior [20]. Two
questions were addressed to the patients at discharge:
what is your opinion of the risk that you (A) will try to
hurt or injure yourself without the intention of killing
yourself, and (B) will try to kill yourself? For each ques-
tion, the patient was given 7 response options: no risk,
low risk, moderate risk, high risk, very high risk, do not
know the risk, or will not answer about the risk. In this
study, no risk was scored as 0 (negative), and the other 6
response options were scored as 1 (positive).
Information regarding gender, age, length of hospital
stay, legal status, and ICD-10 diagnosis was obtained
from hospital records. Violent behavior and violent vic-
timization were recorded during follow-up in a parallel
project performed at the same time [22] and determined
from the hospital records, as were some items from the
Violence Risk-10 (V-RISK-10) screening tool, including
V6, a lack of insight into their illness; V9, unrealistic
planning for the future; and V10, future stress exposure/
vulnerability. Hopelessness has been identified as an im-
portant risk factor for self-harm [23], and at discharge,
the patients’ experience of hopelessness for their own fu-
ture was scored as “yes” or “no” by the therapist.
Outcome variables
The outcome measures included in the analysis were
threats and attempts of suicide and threats and acts of
non-suicidal self-injury (NSSI). A suicide attempt was de-
fined as self-infliction of physical injury with the intention
of killing oneself, and NSSI was defined as inflicting phys-
ical injury upon oneself without the intention of killing
oneself [24]. Suicide attempts and NSSI were categorized
as less severe (without the need for hospitalization) or se-
vere (followed by hospitalization or fatality). All study sub-
jects were scored as “No episodes”, “Yes – episode(s)”, or
“Do not know”. To improve the statistical power, the ana-
lyses were performed by merging threats, less-severe acts,
and severe acts of suicide and NSSI into one common
variable: deliberate self-harm (DSH), which was coded as
0 (no self-harm), or 1 (suicidal or NSSI threat or attempt).
Some of the patients had both suicidal and NSSI be-
haviors at different times during follow-up, and it was
difficult to categorize these behaviors into either the sui-
cidal or NSSI group. Consequently, the patients were
categorized into 3 groups; suicidal group, NSSI group,
and suicidal + NSSI group [3,25].
Results from the 4–6-month and 7–9-month follow-up
periods did not add significant information. For clarity,results are only provided for short-term (0–3 months) and
long-term (0–12 months) periods. Because psychosocial
and biological risk factors may change over time, both the
short- and long-term periods are of interest.
Statistical analysis
The data were analyzed using SPSS version 19.0. Chi-
square tests were used to compare frequencies, and t-tests
and one-way analysis of variance (ANOVA) were used for
continuous variables. Binary logistic regression analyses
were conducted to obtain univariate and multivariate
effect sizes (odds ratio, OR). A block-enter procedure was
used to monitor the progression of the chi-square test to
examine whether each of the factors significantly added to
the variance explained by the model. To address the rela-
tive importance of the various contributing factors, two R2
approximations (Cox & Snell R2 and Nagelkerke R2) were
employed as the lower and upper limits of the extent to
which total variance in DSH could be explained by the
predictors.
Analysis of the area under the curve (AUC) of the re-
ceiver operating characteristic (ROC) was performed to
assess the overall predictive accuracy of the models. The
following predictive validity estimates were also com-
puted: sensitivity (how many of the DSH patients dis-
played a positive test), specificity (how many patients
without DSH displayed a negative test), positive predictive
value (PPV, how many patients with a positive test exhi-
bited DSH), negative predictive value (NPV, how many pa-
tients with a negative test did not exhibit DSH), number
needed to assess (NNA, how many patients would need to
be assessed to identify one true DSH patient, which is
equal to 1/PPV), and the likelihood ratio (LR). The LR
determines the extent to which the odds of an outcome
(e.g., DSH) increase when a test is positive (LR+) and de-
crease when a test is negative (LR–). An LR + value of 3.0
signifies a 3-fold increase in the likelihood of DSH. For
tests with only two outcomes (DSH or not), the LR + and
LR– can be expressed as sensitivity/(1 – specificity) and
(1-sensitivity)/specificity, respectively [26].
Results
A comparison between the follow-up sample (40%) and
the other admitted patients (60%) is shown in Table 1.
Two patients took their lives during the follow-up [3],
and 75 (36%) patients were recorded as exhibiting DSH
at the 1-year follow-up, 52 of whom were hospitalized
again because of DSH. Among these patients, 23 were
re-hospitalized once; 11 underwent 2 re-hospitalizations;
7 experienced 3 re-hospitalizations; 5 underwent 4 re-
hospitalizations; and 6 patients were subjected to 5 re-
hospitalizations related to DSH. Patients exhibiting 3 or
more DSH-related re-hospitalizations (repeated DSH,
DSH-R) constituted 24% of the total sample of DSH






Men 104 (53%) 158 (54%) 0.820
Mean age (years) 42.4 45.7 0.027
Mean hospital stay (days) 20 14 <0.001
Involuntary admittance 42 (21%) 63 (23%) 0.655
Mandatory aftercare 17 (8.6%) 22 (7.5%) 0.799
F1x substance abuse 30 (15%) 44 (15%) 0.898
F10 alcohol abuse 21 (11%) 29 (10%) 0.780
F2x psychotic disorders 29 (15%) 49 (17%) 0.703
F30-31 bipolar disorders 29 (15%) 24 (8.2%) 0.049
F32-39 depressive disorders 54 (28%) 66 (23%) 0.213
F4x anxiety disorders 38 (19%) 55 (19%) 0.704
F6x personality disorders 13 (6.6%) 13 (4.5%) 0.319
Feeling of hopelessness 24 (12%) 33 (14%) 0.484
DSH during hospital stay 14 (7.1%) 0 <0.001
Positive SRS rating 35 (20%) 28 (12%) 0.043
Positive MINI items at discharge (0-6) 2.4 1.8 0.004
Suicide attempt prior to admission 29 (15%) 24 (10%) 0.076
Suicide attempt ever 84 (45%) 67 (28%) <0.001
Suicidal ideation prior to admission 92 (49%) 102 (42%) 0.130
Wish of self-harm prior to admission 73 (39%) 71 (29%) 0.031
Total cholesterol (mmol/liter) 5.0 5.1 0.876
Triglycerides (mmol/liter) 1.4 1.3 0.527
HDL (mmol/liter) 1.3 1.4 0.083
LDL (mmol/liter) 3.3 3.6 0.227
Platelet serotonina 3.5 3.2 0.685
Platelet serotoninb 0.85 0.82 0.922
DSH = deliberate self-harm; SRS = Self-report Risk Scale; MINI = the MINI
Suicidal Scale; HDL = high-density lipoprotein; LDL = low-density lipoprotein.
anmol/109 platelets, not using serotonin reuptake inhibitors (SSRI, SNRI or TCA).
bnmol/109 platelets, using serotonin reuptake inhibitors.
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of DSH-related re-hospitalizations and 44% of all re-
hospitalizations. One DSH-R patient was recorded as only
exhibiting suicidal attempts. The other 17 DSH-R patients
were recorded as displaying at least 1 suicidal attempt and
1 NSSI at different times (suicidal + NSSI group). A
comparison of the non-DSH patients, DSH-R patients,
and patients with 1 or 2 DSH re-hospitalizations or
post-discharge DSH episodes without hospitalization
(1-2 DSH) is presented in Table 2. DSH-R was recorded
for 13 patients within the first 3 months after discharge.
For patients with suicidal behavior only, the odds ratios
[95% CIs] for total cholesterol and TG associated with
12-month suicidal behavior were 1.3 [0.95-1.8] (p = 0.104)
and 1.9 [1.1-3.5] (p = 0.026), respectively. The correspon-
ding values for 12-month NSSI only were 1.2 [0.66-2.3]
(p = 0.524) and 1.8 [0.69-4.7] (p = 0.234); for 12-monthsuicidal behavior + NSSI, the odds ratios for total
cholesterol and TG were 1.3 [0.89-1.9] (p = 0.171) and
2.6 [1.4-4.9] (p = 0.003), respectively.
Eleven of the 18 DSH-R patients had 1 or 2 co-morbid
psychiatric diagnoses, such as alcohol disorders (3 pa-
tients), mild intellectual disability (3), personality disor-
ders (1 borderline and 1 unspecified), bipolar depression
(2), unipolar depression (2), and anxiety disorders (2).
Univariate and multivariate predictive values
TG levels significantly predicted DSH-R at 12 months,
with an OR [95% CI] of 4.2 [1.9-9.4] (p < 0.001). The
3-month OR was 3.2 [1.7-6.3] (p = 0.001). No other
lipids were significant in the 1-2 DSH and DSH-R
groups, and the platelet serotonin levels were also not
significant.
The 3- and 12-month ORs [95% CIs] for the MINI for
DSH-R were 1.7 [1.3-2.4] (p = 0.001) and 1.8 [1.3-2.4]
(p < 0.001), respectively, and the corresponding values
for SRS were 12 [2.5-54] (p = 0.002) and 12 [3.2-44]
(p < 0.001).
When the 9 significant factors associated with post-
discharge DSH-R at 12 months (see Table 2), including
gender, hopelessness, inpatient DSH, a personality dis-
order (PD), violent victimization, a lack of insight, positive
MINI items, SRS, and TG, were entered into multiple re-
gression analyses, the lack of insight and TG were the only
factors that remained significant.
Table 3 shows the results of the block-entry logistic re-
gression analysis of the 9 significant factors and age. Age
was not significant in the univariate analysis but is con-
sidered to be significantly associated with self-harm;
therefore, age was entered into the analysis as the tenth
factor. Gender, age, PD, and TG were entered in the first
step of the analyses; hopelessness, inpatient DSH, vic-
tims of violence, and lack of insight were added in the
second step; and MINI and SRS were added in the third
step.
In the 12-month block-entry regression with the same
10 factors and 1-2 DSH as the inclusion criteria for
the reference group (versus non-DSH patients in the
previous analysis), PD (OR [95% CI] = 9.2 [1.9-44],
p = 0.006) and TG (2.5 [1.1-5.5], p = 0.022) were the only
significant variables in Step 1. Inpatient DSH (29 [1.0-820],
p = 0.047) and TG (3.1 [1.0-9.3], p = 0.049) were significant
in Step 2, and lack of insight (28 [1.0-760], p = 0.047) and
TG (3.7 [1.0-13], p = 0.046) were significant in Step 3.
Similar results were obtained in the block-entry re-
gression analysis at 3 months post-discharge of DSH pa-
tients. High TG level was the only significant factor in
the third step of the stepwise regression when non-DSH
patients were used as the reference group, with an OR
[95% CI] of 7.5 [1.0-55] (p = 0.048). No factors were sig-
nificant in the 3. step of the multiple regression analysis
Table 2 Comparison of patients not showing deliberate self-harm (DSH) with patients exhibiting one or two DSH
episodes and those displaying repeated DSH after discharge
Number of patients (N = 196) No DSH 1-2 DSH DSH-R
n = 121 (62%) n = 57 (29%) n = 18 (9%)
Males/females (%) 59/60 (50/50%) 36/24 (60/40%) 6/12 (33/67%)b*
Mean age, years [95% CI] 43 [40-46] 42 [38-45] 38 [31-45]
Mean hospital stay, days [95% CI] 22 [ 8-27] 20 [16-24] 12 [6-18]a*
Involuntary admissions 25 (21%) 12 (20%) 5 (28%)
Mandatory aftercare 10 (8.4%) 6 (10%) 1 (5.6%)
Inpatient DSH 4 (3%) 3 (5%) 7 (39%)a***b***
Hopelessness at discharge 11 (10%) 7 (13%) 6 (38%)a** b*
Lack of insight“ 41 (35%) 30 (52%)a* 15 (83%)a*** b*
Unrealistic plans“ 43 (37%) 35 (69%)a** 13 (72%)a**
Stress exposure“ 61 (53%) 37 (64%) 11 (61%)
Positive MINI items [95%CI]“ 1.9 [1.5-2.3] 3.0 [2.3-3.6]a** 4.1 [3.3-4.9]a***b*
Positive SRS ratings“ 33 (30%) 26 (50%)a* 15 (83%)a*** b*
Violent offenders after discharge 21 (18%) 15 (25%) 8 (44%)a*
Victims of violence“ 19 (17%) 14 (24%) 10 (56%)a*** b*
Main diagnoses
Substance misuse (F10-19) 19 (16%) 8 (13%) 3 (17%)
Psychoses (F20-29) 18 (15%) 9 (15%) 2 (11%)
Manic/bipolar disorders (F30-31) 19 (16%) 8 (14%) 2 (11%)
Depressive disorders (F32, F34.1) 37 (26%) 26 (15%) 0 a** b* f
Anxiety disorders (F40-49) 24 (20%) 11 (18%) 3 (17%)
Personality disorders (F60-62) 3 (3%) 3 (5%) 7 (39%)a*** b*** c
Blood measures
Total cholesterolmmol/l [95%CI] 4.9 [4.7-5.1] 5.3 [4.9-5.6] 5.3 [4.8-5.9]
LDL“ 3.2 [3.0-3.3] 3.6 [3.3-3.9] 3.6 [3.0-4.1]
HDL“ 1.3 [1.2-1.4] 1.3 [1.1-1.5] 1.2 [1.0-1.4]
Triglycerides“ 1.2 [1.1-1.3] 1.4 [1.2-1.6] 2.1 [1.5-2.6]a***b*
Platelet serotonind 3.3 [2.6-3.8] 3.7 [2.4-5.1] 3.0 [1.9-4.1]
Platelet serotonine 0.88 [0.53-1.2] 0.72 [0.38-1.1] 0.79 [0.27-1.6]
DSH = deliberate self-harm; 1-2 DSH = one or two DSH episodes/re-admissions; R-DSH = three or more DSH re-admissions.
*p ≤ 0.05, ** p ≤ 0.01, ***p ≤ 0.001.
aSignificantly different from non-DSH patients.
bSignificantly different from 1-2 DSH patients.
cAll unstable (borderline) personality disorders.
dnmol/109 platelets [95% CI], not using serotonin reuptake inhibitors (SSRI, SNRI, or TCA).
enmol/109 platelets [95% CI], using serotonin reuptake inhibitors.
fTwo of the DSH-R patients had co-morbid diagnosis of unipolar depression.
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charge) were the reference group. The TG value in the
third step was 3.5 [0.67-18] (p = 0.156).
No significant correlations were found between TG
and the main diagnostic groups. Furthermore, the results
did not change when controlling for diagnoses of dia-
betes or alcohol misuse and for current medication at
the time of admission. Only 1 of the DSH patients was
recorded as having a diagnosis of heart disease.Other predictive values
Finally, to further test possible incremental validity, TG
levels were entered into the analysis together with posi-
tive MINI items (coded 0-6), female gender (coded 0, 1),
PD (coded 0, 1), a lack of insight (coded 0, 1), violent
victimization (coded 0, 1), and SRS (coded 0, 1). TG
levels were coded as follows: 0-25th percentile = 2, 26th-
50th percentile = 1, and 51st-100th percentile = 0. The
ROC-AUC values associated with the 1-year follow-up
Table 3 Stepwise multivariate analyses of the significant factors of patients with three or more re-hospitalizations
caused by DSH 12 months after discharge of index admission
Variance Explained
OR [95% CI] p χ2 (d.f.) p Variancea
Step 1
Female 1.4 [0.32-6.5] 0.638
Age 1.0 [0.96-1.05] 0.696
Personality disorders 36 [4.8-274] <0.001
Triglycerides 3.4 [1.5-7.6] 0.004
Total variance of step 1 33 (4) <0.001 24-44%
Step 2
Female 0.58 [0.03-12] 0.729
Age 1.1 [0.97-1.2] 0.168
Personality disorders 190 [1.1-3200] 0.045
Triglycerides 7.8 [1.6-37] 0.010
Lack of insight 29 [1.5-570] 0.025
Victims of violence 19 [1.2-320] 0.036
Hopelessness 12 [0.69-240] 0.087
Inpatient DSH 63 [0.88-4600] 0.058
Increase from step 1 (hopelessness, victims of violence,lack of insight, inpatient DSH) 29 (4) <0.001 17-31%
Total variance of step 2 62 (8) <0.001 41-75%
Step 3
Female 13 [0.59-280] 0.353
Age 1.2 [0.97-1.5] 0.089
Personality disorders 1100 [0.36-34x106] 0.087
Triglycerides 102 [0.76-14000] 0.064
Victims of violence 2500 [0.52-12x106] 0.070
Lack of insight 2600 [0.52-13x106] 0.071
Hopelessness 1.4 [0.02-98] 0.872
Inpatient DSH 1.1 [0.003-360] 0.978
Self-report risk scale 0.51 [0.02-15] 0.699
MINI suicidal scale 4.7 [0.99-22] 0.051
Increase from step 2 (by MINI and self-report risk scale) 12 (2) 0.003 6-10%
Total variance of step 3 74 (10) <0.001 47-85%
DSH, deliberate self-harm.
a“pseudo R2” = Cox & Snell R2 – Nagelkerke R2 estimates (of the factors’ contribution to the total variance).
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Table 4.
Other predictive values are displayed in Table 5. The
cut-off values shown in Table 5 were based on the coor-
dinates of all of the recorded sensitivities/specificities.
For both models, the cut-off values constituted the lar-
gest sum of the sensitivity + specificity.
Discussion
The main finding of the present study was that TG
showed significant incremental validity in the risk assess-
ment of DSH-R at 3 and 12 months after discharge. Theapplied bio-psychosocial approach, including the MINI
Suicidal Scale, psychosocial risk factors, and TG, pro-
duced a PPV that was twice as high as that obtained
using the MINI alone. Furthermore, TG enhanced the
predictive validity of DSH when comparing DSH-R pa-
tients with 1-2 DSH patients. One possible explanation
for this finding is that an elevated TG level reflects stress
activation in the noradrenergic nervous system. Studies
have shown that psychological distress can lead to in-
creased TG levels [27-29]. The increase in TG following
psychological distress results from direct psychological
sympathetic activation and is not a metabolic effect [30].
Table 4 The area under the curve of the receiver operator characteristic (AUC) for one-year DSH-R
Compared with non-DSH Compared with 1-2-DSH
AUC [95% CI] p AUC [95% CI] p
TG 0.74 [0.61-0.86] 0.001 0.69 [0.55-0.83] 0.017
SRS 0.77 [0.65-0.88] <0.001 0.68 [0.54-0.81] 0.027
MINI Suicidal Scale 0.81 [0.72-0.91] <0.001 0.62 [0.48-0.75] 0.146
Other variables (OV)a 0.86 [0.74-0.97)] <0.001 0.81 [0.69-0.93)] <0.001
MINI + TG 0.85 [0.77-0.94] <0.001 0.71 [0.57-0.85] 0.009
MINI + OV 0.89 [0.80-0.98] <0.001 0.76 [0.64-0.89] 0.001
OV + TG 0.89 [0.82-0.97] <0.001 0.87 [0.77-0.96] <0.001
MINI + OV + SRS + TG 0.91 [0.83-0.99] <0.001 0.82 [0.70-0.94] <0.001
OV + SRS + TG 0.92 [0.85-0.98] <0.001 0.88 [0.79-0.97] <0.001
DSH = deliberate self-harm; DSH-R = repeated DSH; SRS = Self-report Risk Scale; TG = triglycerides;
aFemale, personality disorder, victims of violence, lack of insight.
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ral anxiety disorders [31]. Albrink et al. found a signi-
ficant positive association between TG and obesity [32].
Stress has been identified as a common factor in obese
individuals, and the neurobiology of stress overlaps sig-
nificantly with that of appetite and energy regulation
[33]. However, measurements of lipid levels after admis-
sion may not accurately reflect the lipid levels occurring
prior to self-harm actions following discharge. Thus,
monitoring TG levels near the time of stress exposure
may improve the detection of this association.
Although there were no apparent differences in the
risk of stress exposure between the 3 groups examined
in this study at discharge, the DSH-R patients may have
had a lower stress tolerance or less efficient coping skills.
A lack of insight may contribute to increased vulnera-
bility and a reduced ability to avoid stressful situations,
which may also be the case for individuals with unstable
personality disorders [34]. Furthermore, stress or stress-
related conditions or symptoms or the risk of exposure
to future stressful situations may have been ignored by
hospital staff when rating the “risk of stress exposure”
(V10) at discharge. Identifying a subgroup with a high
risk of self-harm resulting from increased psychological
distress may be of clinical importance both for treatment
(coping with and reducing internal stress) and preven-
tion (reducing external environmental stress). Regarding
prevention, during the 1-year follow-up, victimization
was increased in the DSH-R group compared with theTable 5 Comparison of predictive values and likelihood ratios
patients
Cut off Sens Spec
MINI (0-6) 3.5 0.78 0.75
MINI + OVa + SRS + TG (0-14) 8.5 0.78 0.92
MINI = the MINI Suicidal Scale; OV = other significant variables; SRS = Self-report Sca
predictive value; NPV = negative predictive value; NNA = number needed to assess;
aFemale, personality disorders, victims of violence, lack of insight.other subgroups, indicating increased stress exposure,
stress reactions, and stress vulnerability, which is in
agreement with earlier reports of an association between
victimization and DSH [35,36].
Although depression and psychosis are strong risk
factors for self-harm [1], these factors were significantly
underrepresented in the DSH-R group and in all self-
harming patients in this study [3]. However, several fac-
tors may explain these results: (i) there was a high preva-
lence of self-harm in this study; (ii) patients with
depression or psychoses are known to be at self-harm
risk, and these patients were not discharged before the
risk was considered low and these patients may have re-
ceived sufficient treatment and self-harm monitoring
after being discharged; and (iii) patients with alcohol
abuse or personality disorders and repeated admissions
may have been treated inadequately, or co-morbidity
may have been overlooked, in which case self-harm risk
may have been ignored [37].
Previous studies revealed a negative correlation between
body mass index (BMI) and suicide [38,39]. However, one
recent investigation conducted in Taiwan demonstrated
increased suicide risk in both underweight and obese indi-
viduals [40]. Thus, the interpretation and understanding
of this association are still inadequate. A greater body
weight reduces the fatality of poisoning and shifts suicidal
acts away from lethal means such as hanging, but it
remains difficult to exclude other possible explanations
for the reported correlation, such as psychiatric disordersfor the MINI and the MINI + OVa + SRS + TG for DSH-R
PPV NPV NNA LR+ LR-
0.30 0.96 3.3 2.9 0.24
0.64 0.96 1.6 9.8 0.24
le; TG = triglycerides; Sens = sensitivity; Spec = specificity; PPV = positive
LR+ = positive likelihood ratio; LR- = negative likelihood ratio.
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http://www.biomedcentral.com/1471-244X/14/54that could lead to weight loss and suicidal ideation [41],
including depression or anorexia. Our finding of an asso-
ciation between high TG and DSH-R is contrary to the
BMI-related “protective” effect but concurs with results of
studies that have found a potentially positive association
between obesity and stress [33].
Other research has addressed the importance of focus-
ing on high sensitivity in screening for self-harm repeaters
in emergency settings [7]. The direct clinical application
of AUC and OR values can be difficult. Other predictive
values may add important information regarding the cli-
nical applicability of screening tools. For most risk assess-
ment instruments, the identification of individuals at risk
is acceptable (high sensitivity), but the total predictive
value is often low, with many false positives (low specifi-
city). Compared with the MINI Suicidal Scale, the applied
multifaceted bio-psychosocial screening method exhibited
increased specificity, as demonstrated by a decrease in
NNA values from 3.3 to 1.6. This finding indicates an in-
creased positive predictive value and implies that a total of
2.3 or 0.6 patients, respectively, would have been unneces-
sarily assessed for DSH-R risk for every true DSH-R pa-
tient identified. The increase in the positive likelihood
ratio from 2.9 to 9.8 indicates that a positive MINI test
result increases the likelihood of a patient exhibiting
DSH-R by 2.9-fold, whereas the increase in likelihood is
9.8-fold for a positive bio-psychosocial test. Our results
suggest that easily accessible bio-psychosocial risk factors
could be employed to screen for DSH risk in emergency
settings.
Limitations
Only one hospital was involved in the present work, and
the study sample was small, consisting of 40% of the
potential subjects. There were some differences between
the study sample and the other patients (non-consenting
patients and patients lost to follow-up). Moreover, our
sample of DSH-R patients was small, and the study popu-
lation was selective relative to the community cohorts
included in various BMI studies [38,39]. These factors
limit the generalizability of the obtained results. However,
there was a higher incidence of self-harm-related variables
in the follow-up sample. Records of self-harm behavior
can be difficult to obtain and may suffer from under-
reporting. Although the raters (baseline variables) and re-
corders (outcome variables) involved in the present study
were responsible for different parts of the research, they
all worked in the same clinical department. While the re-
corders were blinded to the baseline measures and ratings,
there may still have been some communication that could
have threatened the ideal performance of independent
measurements. However, the clinicians’ familiarity with
the patients may have counteracted the underreporting of
self-harm episodes. Somatic illnesses that may influencelipid levels, such as heart disease and diabetes, could
have been underreported in the psychiatric records, even
though the patients were treated during their stay in the
ward.
Alcohol consumption, cigarette smoking, and obesity
increase TG levels [32,42-44]. Beyond recording the
ICD-10 diagnosis of alcohol abuse, these factors were
not controlled for in the study. However, smoking de-
creases BMI and counteracts the alcohol-related increase
in TG levels (Wannamethee & Shaper, 1992), and there
is no available evidence of interaction effects between
alcohol use, smoking, and BMI in relation to suicide risk
[40]. We did not control for dietary patterns or stress-
related dietary changes, such as high carbohydrate in-
take, that may have caused elevated TG levels [33,45],
and no anxiety scales or tools were used in the study be-
yond the diagnosis of anxiety disorders.
Conclusions
In summary, TG levels explained variability in self-
harming behavior that was not explained by the other risk
factors assessed. This finding may help to identify a sub-
group of patients characterized by repeated self-harming
behavior. Thus, a bio-psychological approach appears to
be promising, at least for high-risk subgroups. Further
studies controlling for anxiety and stress-related measures,
obesity measures, and alcohol consumption and smoking
patterns are necessary to further develop and validate this
model.
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